Jacobio Pharmaceuticals News and Activities
Presence
Headquarters: China
Jacobio Pharmaceuticals is a company listed under the stock ticker 1167 (HK).
Executives
View the org chart displaying its 23 main executives
Most searched biographies at Jacobio Pharmaceuticals
- Yinxiang Wang, Chief Executive Officer and Chairman of the Board
- Hu Yunyan, Executive Director
- Wang Xiaojie, Executive Director
Popular executive movements at Jacobio Pharmaceuticals
- Yan Chen has joined the company as Vice President of Chemistry, Manufacturing and Controls (posted on May 18 2026).
- Andrea Wang-Gillam who was Chief Medical Officer and Head of Global Affairs, becomes Co-Chief Executive Officer and Chief Medical Officer (posted on November 13 2025).
Create your alert
to follow the executive moves at Jacobio Pharmaceuticals.
Pharmaceuticals
Jacobio Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Jacobio Pharmaceuticals
- Jacobio Pharma’s BET Inhibitor JAB-8263 Approved for Phase IIa Clinical Trial in Rheumatoid Arthritis in China | Jacobio Pharma
- Jacobio Pharma Appoints Dr. Yan Chen as Vice President of CMC to Accelerate Development of Its Small Molecule and xADC Platforms | Jacobio Pharma
- Jacobio-Licensed KRAS G12C and SHP2 Inhibitor Combination Receives Breakthrough Therapy Designation in China | Jacobio Pharma
- Jacobio Pharma Receives US$100 Million Upfront Payment from AstraZeneca | Jacobio PharmaCopy linkFind any service
- Jacobio Announces 2025 Annual Results | Jacobio PharmaCopy linkFind any service
- Glecirasib Colorectal Cancer Data Published in The Lancet Gastroenterology & Hepatology | Jacobio PharmaCopy linkFind any service
- Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73 | Jacobio PharmaCopy linkFind any service
- Jacobio’s KRAS G12C and SHP2 Combination Therapy Published in The Lancet Respiratory Medicine | Jacobio PharmaCopy linkFind any service
- Company News | Jacobio Pharma
- Jacobio Pharma Announces Establishment of Co-CEO System | Jacobio PharmaCopy linkFind any service
- View more press releases Close
Social media about Jacobio Pharmaceuticals
- Jacobio Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Jacobio Pharmaceuticals on LinkedIn, X (Twitter) & YouTube
